Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Interest & Investment Income (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Interest & Investment Income of $3.7 million for Q2 2026, down 12.6% from $4.23 million a year earlier and down 0.6% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Interest & Investment Income (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Tarsus Pharmaceuticals was $15.48 million, up 0.2% year-over-year; for FY2025, it came in at $15.75 million, up 4.9% from FY2024.

  • Annual Interest & Investment Income has increased for three consecutive years, with a three-year compound annual growth rate of 65.1% (FY2022 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Interest & Investment Income was $15.01 million in FY2024 (+45.2%), $10.34 million in FY2023 (+195.4%) and $3.5 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q1 2025.
  • On a year-over-year basis, Interest & Investment Income increased in six of the last eight quarters, with growth averaging 10.5%.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 649.5%; the weakest was Q2 2026, with a decline of 12.6%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $3.72 million (Q1 2026), $3.95 million (Q4 2025) and $4.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn 3.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.70 Mn
Mar 31, 2026 3.72 Mn
Dec 31, 2025 3.95 Mn
Sep 30, 2025 4.11 Mn
Jun 30, 2025 4.23 Mn
Mar 31, 2025 3.45 Mn
Dec 31, 2024 3.65 Mn
Sep 30, 2024 4.12 Mn
Jun 30, 2024 4.13 Mn
Mar 31, 2024 3.12 Mn
Dec 31, 2023 2.98 Mn
Sep 30, 2023 2.84 Mn
Jun 30, 2023 2.23 Mn
Mar 31, 2023 2.29 Mn
Dec 31, 2022 2.13 Mn
Sep 30, 2022 1.06 Mn
Jun 30, 2022 297,000.00
Sep 30, 2021 8,000.00
API Access

Tarsus Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TARS&period=max&api_key=YOUR_API_KEY